跳至主導覽
跳至搜尋
跳過主要內容
長庚大學學術能量集萃 首頁
說明與常見問題
English
中文
首頁
學者概覽
研究單位
研究產出
研究計畫-專案
獎項
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
郭 昶甫
臨床副教授
,
醫學系
電子郵件
D000018227
cgu.edu
tw
h-index
h10-index
h5-index
7937
引文
45
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
6214
引文
35
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1725
引文
23
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2008
2024
每年研究產出
概覽
指紋
網絡
研究計畫-專案
(22)
研究產出
(264)
獎項
(3)
相近領域學者
(6)
指紋
查看啟用 Chang-Fu Kuo 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Patient
100%
Cohort Analysis
42%
Inpatient
36%
Incidence
35%
Mortality
31%
Association
24%
Rheumatoid Arthritis
24%
Diagnosis
23%
Health
23%
Gout
22%
Learning
21%
Population Research
21%
Woman
21%
Age
19%
Hazard Ratio
19%
Malignant Neoplasm
18%
Family
17%
Atrial Fibrillation
16%
Cohort Effect
15%
Survival
15%
Odds Ratio
14%
Therapeutic Procedure
13%
Death
13%
Pregnancy
12%
Analysis
12%
Prevalence
11%
Hyperuricemia
11%
Heritability
11%
Child
11%
Disease
11%
Mortality Rate
10%
Adult
10%
Cardiovascular Disease
10%
Intelligence
10%
Serum
9%
All Cause Mortality
9%
Development
9%
Warfarin
9%
Antithrombotic
9%
Hospital
9%
Comorbidity
9%
Family History
9%
Person
9%
Autoimmune Disease
8%
Follow up
8%
Brain Ischemia
8%
Glycon
8%
Dermatomyositis
8%
Polymyositis
8%
Man
8%
Nursing and Health Professions
Incidence
36%
Cohort Analysis
28%
Gout
26%
Mortality
21%
Rheumatoid Arthritis
21%
Confidence Interval
19%
Data Base
19%
Epidemiology
17%
Prevalence
16%
Diagnosis
15%
Comorbidity
12%
Atrial Fibrillation
11%
National Health Insurance
11%
Patient
11%
Malignant Neoplasm
10%
Survival
10%
Mortality Rate
10%
Control
10%
Death
10%
Hazard Ratio
9%
Anticoagulant Agent
8%
Odds Ratio
7%
Osteoarthritis
7%
Hospitalization
7%
All Cause Mortality
7%
Diseases
7%
Analysis
7%
Cardiovascular Disease
6%
Inpatient
6%
Family History
6%
Clinical Practice
6%
Hyperuricemia
6%
Hospital
6%
Warfarin
6%
Pregnancy Outcome
6%
Primary Medical Care
5%
X Ray Film
5%
Dermatomyositis
5%
Polymyositis
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
34%
Rheumatoid Arthritis
25%
Atrial Fibrillation
20%
Anticoagulant Agent
20%
Warfarin
13%
Bleeding
12%
Incidence
10%
Mortality
9%
Chronic Kidney Failure
9%
Survival
9%
Malignant Neoplasm
8%
Hyperuricemia
8%
Antivitamin K
8%
Prevalence
7%
Osteoarthritis
7%
Brain Ischemia
7%
Epidemiology
6%
Gout
6%
Mortality Rate
6%
Embolism
6%
Uric Acid
6%
Death
6%
Comorbidity
5%
Cross-Sectional Study
5%
Polymyositis
5%
Dermatomyositis
5%
Population Study
5%
